AbCellera is clinical-stage biotech company focused developing antibody-based medicines in the areas of endocrinology, women’s health, immunology and oncologyabcellera.com Vancouver, British ColumbiaJoined January 2016
Visit our poster at Antibody Engineering & Therapeutics Europe 2025 to learn how we leverage multiple T-cell engager building blocks to generate molecules with in vivo efficacy.
Read more about our TCE platform: ow.ly/JzZt50W5EbV#AntibodyEngineering
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
ow.ly/wZ1o50VSUVU
Visit our poster at #PEGSSummit to learn how multiple T-cell engager (TCE) building blocks can be leveraged to tailor TCE design for diverse tumor targets.
Read more about our TCE platform: ow.ly/CNgJ50VO9uK
Visit our poster at #SIDSanDiego25 to learn about a novel, fully human and half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of moderate-to-severe atopic dermatitis.
Read more about our pipeline here: ow.ly/cTE650VMgbU
Visit our poster at #AACR25 to see how combining diverse CD3- and tumor-binding antibodies and empirically testing for optimal combinations can generate T-cell engagers (TCEs) with in vivo efficacy.
Read more about our TCE platform here: tinyurl.com/37p49n32#ImmunoOncology
Visit our poster at #festivalofbiologics in San Diego to learn how we’re leveraging our T-cell engager (TCE) platform to design and optimize TCEs for solid tumor targets.
Read more about our TCE platform: tinyurl.com/mrh67e5w
24K Followers 624 FollowingInvestor | 21+ yrs in Energy Industry | Geophysicist Once
Personal Views & Opinions only
(No Financial Advice | Do your own DD | Don't fall for SCAMs)
537 Followers 392 Followingdisclaimer:🚨
tweets are my own opinions & should not be seen as investment advice
Corporate-finance & stocks (sp) are associated with risks & uncertainties📌
31K Followers 631 FollowingIt’s not what you buy, it’s what you pay. And success in investing doesn’t come from buying good things, but from buying things well. -Howard Marks
8K Followers 462 FollowingOrdförande i den rikstäckande organisationen Snedgungornas Riksförbund. Har kortat SPX och hamnat snett i livet. Andra meriter: Har klippkort på psykakuten
12K Followers 1K FollowingMD, DMSc - Biopharma/Pharma investment - Accounts with irrelevant or offensive comments are muted, but I only block accounts in extreme cases.
2 Followers 13 FollowingThinking about the future. Researching $ABCL. Just learning about biotech to educate me & others. Improving English. $TSLA investor. Own opinions, no advice.
5K Followers 897 FollowingGeopolitical investment news, literature, remote classes for grades 3-12 in ELA, test review, or media literacy, canvas art, painted pots, gardening, and more!
1K Followers 2K FollowingSyntax Strategic is a strategic communications and advocacy company that specializes in public relations, media relations, digital strategy and advocacy.
183K Followers 70 FollowingClosing Bell hosted by @ScottWapnerCNBC airs live Monday-Friday from 3PM-4PM ET on CNBC. Taking you through the most important hour of trading and beyond.
5K Followers 333 FollowingOfficial Teva Pharmaceuticals Europe Twitter feed. We develop, produce, and market medicines that make a difference in people's lives.
25K Followers 6K FollowingCommitted to advancing life science research with innovative reagents, tools, and services. For product and technical support, email [email protected].
7.3M Followers 2 FollowingThis account is no longer active. Follow @X and @Safety for updates, or get help via our Help Center: https://t.co/y8BGBV9sv9
9.8M Followers 101 FollowingThe first word in business news. Singapore newsletter: https://t.co/RtyaUOdLdF Newsletters: https://t.co/nWaCxHSKuU Podcasts: https://t.co/096e9xMbPz
20.9M Followers 1K FollowingSign up for our newsletters and alerts: https://t.co/QevH0DLQi8 | Got a tip? https://t.co/iXIigdPjEZ | For WSJ customer support: https://t.co/DZgH9n53qg
4.5M Followers 460 FollowingCutting-edge research, news, commentary, and visuals from the Science family of journals. Follow @NewsfromScience for stories from our News team.
2.2M Followers 2K FollowingNature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
4K Followers 1K FollowingOur 1,200 researchers, postdocs, students and staff drive innovation and excellence through collaborative research in life sciences.
2K Followers 78 FollowingI'm a former newspaper reporter: Peterborough Examiner, Ottawa Journal, Toronto Star, Ottawa Citizen/Sun. That's Lake Huron up top.
20K Followers 1K FollowingJohn Cook is the co-founder of GeekWire, a national online news site and community with strong roots in the Pacific Northwest.
929 Followers 464 FollowingSr. producer at Seattle Eats and other @KUOW shows
she/her
avid rock climber — crochet-er — connoisseur of so-bad-it's-good movies — lover of the em dash
1K Followers 56 FollowingZymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases.
151 Followers 13 FollowingHarbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology.
237K Followers 708 FollowingWe are uniting science, technology and talent to get ahead of disease together.
Our community guidelines: https://t.co/NdSNH7YhFc
2K Followers 668 FollowingThe official twitter account for the Informa Connect Antibody Engineering & Therapeutics portfolio. Your home for all things protein therapeutics.